Novel Approaches to Target MECOM/EVI1 in AML
Clinical trial NCT05839392 · RECRUITING
Trial details
- NCT number
- NCT05839392
- Sponsor
- Gruppo Italiano Malattie EMatologiche dell'Adulto
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-13
- Primary completion
- 2026-12-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.